Skip to main content
NVDA-2.26%AAPL+3.21%GOOGL+0.77%MSFT-0.04%AMZN-0.40%TSM-1.36%SPCX+0.37%AVGO-0.72%META-1.33%TSLA-1.04%SKHY-4.44%MU-4.49%BRK-B0.00%LLY+0.20%JPM-0.48%WMT-0.02%AMD-3.11%V-0.12%XOM+0.79%ASMLa-1.66%JNJ-0.20%INTC-5.00%MA-0.45%0700.HK-1.94%1398.HK+0.79%ORCL-4.82%ABBV+1.36%BAC-0.30%CSCO-1.41%CVX-0.30%COST-0.12%KO+0.49%LRCX-5.25%CAT-1.33%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.89%HSBA.L-1.30%DELL-4.01%PG+0.19%MS-1.04%GE-0.53%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.14%HD-1.74%0939.HK+1.66%GS-1.17%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.43%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.26%EURJPY-1.25%USDJPY-1.24%CADJPY-1.20%NZDCHF-1.05%USDZAR+1.04%USDSEK+0.95%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.76%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%GBPAUD+0.59%USDMXN+0.58%CHFNOK+0.56%AUDSGD-0.56%USDPLN+0.45%GBPTRY+0.41%NZDSGD-0.41%CADCHF+0.40%USDCHF+0.39%NOKJPY-0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.26%AUDCHF-0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.06%PLNJPY+0.06%AUDNOK+0.06%EURCZK-0.06%CHFSGD-0.05%EURCAD-0.05%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%USDCAD-0.02%EURUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.18%UKOIL+5.85%USOIL+5.68%GAGUSD-5.47%XAGUSD-5.47%HG1-4.85%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.59%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.36%ETHUSD-0.01%USDTUSD-0.02%XRPUSD-2.86%SOLUSD-1.55%TRXUSDT+0.21%ZECUSDT-9.15%DOGEUSD-2.40%XMRUSDT+0.31%LINKUSD-1.28%XLMUSD-1.47%BCHUSDT-9.71%LTCUSD-1.65%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.05%SUIUSD-4.19%TAOUSDT-5.53%AAVEUSD-1.81%DOTUSDT-1.74%ICPUSDT-0.47%ONDOUSDT-3.29%WLDUSDT-3.39%ATOMUSDT-3.00%ARBUSDT-0.64%JUPUSDT-3.39%INJUSDT-2.11%STXUSDT-4.53%FETUSDT-2.80%TIAUSDT-1.13%PYTHUSDT-1.22%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.61%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.54%IOTAUSDT-4.02%AXSUSDT-2.25%FARTCOINUSDT-2.66%EOSUSDT-2.78%DYDXUSDT-2.47%ORDIUSDT-0.86%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.26%AAPL+3.21%GOOGL+0.77%MSFT-0.04%AMZN-0.40%TSM-1.36%SPCX+0.37%AVGO-0.72%META-1.33%TSLA-1.04%SKHY-4.44%MU-4.49%BRK-B0.00%LLY+0.20%JPM-0.48%WMT-0.02%AMD-3.11%V-0.12%XOM+0.79%ASMLa-1.66%JNJ-0.20%INTC-5.00%MA-0.45%0700.HK-1.94%1398.HK+0.79%ORCL-4.82%ABBV+1.36%BAC-0.30%CSCO-1.41%CVX-0.30%COST-0.12%KO+0.49%LRCX-5.25%CAT-1.33%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.89%HSBA.L-1.30%DELL-4.01%PG+0.19%MS-1.04%GE-0.53%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.14%HD-1.74%0939.HK+1.66%GS-1.17%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.43%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.26%EURJPY-1.25%USDJPY-1.24%CADJPY-1.20%NZDCHF-1.05%USDZAR+1.04%USDSEK+0.95%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.76%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%GBPAUD+0.59%USDMXN+0.58%CHFNOK+0.56%AUDSGD-0.56%USDPLN+0.45%GBPTRY+0.41%NZDSGD-0.41%CADCHF+0.40%USDCHF+0.39%NOKJPY-0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.26%AUDCHF-0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.06%PLNJPY+0.06%AUDNOK+0.06%EURCZK-0.06%CHFSGD-0.05%EURCAD-0.05%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%USDCAD-0.02%EURUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.18%UKOIL+5.85%USOIL+5.68%GAGUSD-5.47%XAGUSD-5.47%HG1-4.85%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.59%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.36%ETHUSD-0.01%USDTUSD-0.02%XRPUSD-2.86%SOLUSD-1.55%TRXUSDT+0.21%ZECUSDT-9.15%DOGEUSD-2.40%XMRUSDT+0.31%LINKUSD-1.28%XLMUSD-1.47%BCHUSDT-9.71%LTCUSD-1.65%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.05%SUIUSD-4.19%TAOUSDT-5.53%AAVEUSD-1.81%DOTUSDT-1.74%ICPUSDT-0.47%ONDOUSDT-3.29%WLDUSDT-3.39%ATOMUSDT-3.00%ARBUSDT-0.64%JUPUSDT-3.39%INJUSDT-2.11%STXUSDT-4.53%FETUSDT-2.80%TIAUSDT-1.13%PYTHUSDT-1.22%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.61%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.54%IOTAUSDT-4.02%AXSUSDT-2.25%FARTCOINUSDT-2.66%EOSUSDT-2.78%DYDXUSDT-2.47%ORDIUSDT-0.86%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
MP

Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ • Healthcare

$98.3
-$1.23 (-1.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$98.02
Previous Close$98.3
Day Range$97.01 - $101.5
Avg. Volume (3M)498.6K
Market Cap$6B
52 Week Range
$63.23$130
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$176.2M100%
Gross Profitminus cost of goods$145.8M83%

In plain terms: out of every $100 in revenue, Mirum Pharmaceuticals, Inc. currently loses $38.

Fundamentals & Financials

Revenue (TTM)
$618M
Net Income (TTM)
-$860.2M
EPS (TTM)
-$14.56
ROA (TTM)
-82.32%
Current Ratio
2.86

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-650.0%Q1 2026-$0.11
-3257.5%Q2 2026-$13.43
-42.8%Q3 2026-$1.06
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. develops and commercializes therapies for serious rare and orphan diseases as a biotechnology company listed on NASDAQ under MIRM. The business generated $521.3 million in FY2025 revenue, centered on liver-disease treatments and a pipeline aimed at several cholestatic conditions.

Name
Mirum Pharmaceuticals, Inc.
CEO
Christopher Peetz
Website
www.mirumpharma.com
Industry
Healthcare
Year Founded
2018
Employees
433

Today's Snapshot

AI-generated

MIRM is trading 2% higher at 100.26, outperforming a weaker sector. Mirum Pharmaceuticals brought in a new chief medical officer.

Trading Volume

Below 10d avg (441.9K)

319.4K

vs S&P 500 Today

Outperforming Market

+2.60%

Updated: September 10, 2026 at 19:18 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
MIRM registers a modest sell stance amid a mixed timeframe picture where short-term averages and VWAP offer slight support but medium-term moving averages sit overhead as resistance. Momentum indicators are broadly neutral to mildly negative, MACD near zero and RSI around midrange, while ADX indicates only moderate trend strength. Notably, on-balance volume and VWAP are positive, suggesting accumulation that has yet to overcome medium-term resistance. Volatility is moderate. Technical takeaway: sell—mixed signals across timeframes with medium-term resistance outweighing short-term support.
All signals
  • EMA (5 indicators)$95.21 - $103.12
    Sell
  • RSI (14)47.08
    Neutral
  • Stochastic %K (14, 3, 3)54.73
    Neutral
  • MACD Level (12, 26)-1.54
    Neutral

Peers & Related Assets

PRAXPraxis Precision Medicines, Inc.
$345.3-2.0%
TVTXTravere Therapeutics, Inc.
$66.22+0.2%
LGNDLigand Pharmaceuticals Incorporated
$288.05-0.3%
ACADACADIA Pharmaceuticals Inc.
$27.68+0.4%
DYNDyne Therapeutics, Inc.
$19.19-5.5%
ADMAADMA Biologics, Inc.
$9.45-0.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.